SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 9.27% growth in the revenue at Rs. 16326.70 millions for the quarter ended September 2024 as compared to Rs. 14941.40 millions during the year-ago period.A slim rise of 14.59% was recorded in the Net profit for the quarter ended September 2024 to Rs. 3586.10  millions  From Rs. 3129.40 millions.Operating Profit saw a handsome growth to 4994.40 millions from 4363.90 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 16326.70 14941.40 9.27 31902.80 29731.40 7.30 58489.10 53487.30 9.35
Other Income 604.80 555.10 8.95 1278.10 1115.10 14.62 2482.70 1541.50 61.06
PBIDT 4994.40 4363.90 14.45 9577.80 8473.90 13.03 17013.70 13597.80 25.12
Interest 25.00 31.30 -20.13 52.50 64.70 -18.86 124.50 159.90 -22.14
PBDT 4969.40 4332.60 14.70 9525.30 8409.20 13.27 16889.20 13437.90 25.68
Depreciation 175.10 178.40 -1.85 358.80 350.10 2.49 711.70 699.70 1.72
PBT 4794.30 4154.20 15.41 9166.50 8059.10 13.74 16177.50 12738.20 27.00
TAX 1208.20 1024.80 17.90 2300.30 2027.30 13.47 4165.30 3244.10 28.40
Deferred Tax -2.10 -18.00 -88.33 -23.70 -35.60 -33.43 10.70 -11.90 -189.92
PAT 3586.10 3129.40 14.59 6866.20 6031.80 13.83 12012.20 9494.10 26.52
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 30.59 29.21 4.74 30.02 28.50 5.33 29.09 25.42 14.42

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×